Results 181 to 190 of about 71,938 (313)
Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy. [PDF]
Jaber A +21 more
europepmc +1 more source
Cell therapy for Duchenne muscular dystrophy: promises, challenges, and controversies. [PDF]
Łoboda A, Dulak J.
europepmc +1 more source
Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors
Yoshitsugu Aoki +3 more
openalex +2 more sources
Exploring the Role of Telemedicine in Duchenne Muscular Dystrophy: Benefits and Challenges. [PDF]
Wasilewska E +10 more
europepmc +1 more source
Cardioprotection in Duchenne muscular dystrophy
Anjali Tiku Owens, Mariell Jessup
openaire +2 more sources
Therapeutic options for Duchenne muscular dystrophy: hope or hype? [PDF]
Mah JK.
europepmc +1 more source
Multiomics Analysis of the mdx/mTR Mouse Model of Duchenne Muscular Dystrophy [PDF]
Douglas W. Van Pelt +9 more
openalex +1 more source

